Category Archives: Meetings

Forbes Health Summit: Industry Leaders Ponder the New World of Consumer-Driven Care

In health care, it is the lowly consumer who is now calling the shots, driving product and process innovation in areas ranging from electronic medical records [EMR] to retail health clinics. This was the main theme among discussants at the Forbes magazine Healthcare Summit held here in New York on October 10.  The central question:  […]
Also posted in leadership, patient education, R&D, Strategy | Tagged , , , , , , , , , , , | Leave a comment

Specialty Drugs: A Tempting Target, But What to Do?

A key issue for biopharma marketers today is balancing cost and value factors around specialty biologic drugs, particularly those for cancer and other high profile, life-altering diseases.  The financial and reputational stakes for players in this hotly contested commercial space are high, compounded by a startling lack of awareness of the incentives that drive specific […]
Also posted in Biotech, Market Access, pricing, Strategy | Tagged , , , , , , , , | Leave a comment

Why the Slow Take-up of Comparative Effectiveness Research? It's Time and Money, Says a New PCORI Survey

Earlier this week, the federal government’s Patient Centered Outcomes Research Institute (PCORI) unveiled a new survey, revealing that both patients and clinicians want in health research to focus on one thing: improving outcomes. A panel of healthcare providers discussed how findings will impact the structure and content of comparative effectiveness research (CER), advocating patient-centric dissemination […]
Also posted in healthcare, Medical Education, multimedia, Patient Communication, patient education, Strategy, Technology | Tagged , , , , , , , , | Leave a comment

The Sunshine Act: Cloudier Still?

With the recent release of the Patient Protection Sunshine Act (PPSA), the Center for Medicare and Medicaid Services (CMS) has established reporting requirements to ensure that drug manufacturers properly disclose payments to physicians in areas of research, continuing medical education, etc. However a key uncertainty is the issue of state pre-emption. While state and local […]
Also posted in compliance, Legal, Manufacturing, Medical Education, Regulatory | Tagged , , | 1 Comment

Pharma's Promotional Spend: What's the Right Target?

Global consultancy Cegedim has released its latest survey on how and where big Pharma puts its promotional dollar. Pharmaceutical Promotional Spend: Global Trends reports that spending in emerging markets significantly increased last year, while Europe and US declined slightly.  Although overall promotion spending remained flat worldwide at $90 billion, the US still accounts for the […]
Also posted in Advertising, Emerging Markets, Europe, Global, Marketing, Sales, social media, Strategy, Technology | Tagged , , , , , | Leave a comment
  • Categories

  • Meta